Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders
- 1 May 2012
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1822 (5) , 748-752
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Biliverdin reductase-A protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairmentBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease☆Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Age-related loss of phospholipid asymmetry in APP /APP x PS-1 /PS-1 human double mutant knock-in mice: Relevance to Alzheimer diseaseNeurobiology of Disease, 2010
- Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunctionNeurobiology of Disease, 2009
- Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolismNature Neuroscience, 2008
- Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer diseaseNeurobiology of Disease, 2008
- Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's diseaseBrain Research, 2007
- Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and α-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: Implications for Alzheimer's diseaseFree Radical Biology and Medicine, 2007
- In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: Relevance to Alzheimer’s disease and other oxidative stress-related neurodegenerative disordersFree Radical Biology and Medicine, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006